Table 3.
Patient characteristics according to lymphocyte recovery on Day +100
| Lymphocyte recovery Day +100 < 0.75 x 109/L | Lymphocyte recovery Day +100 ≥ 0.75 x 109/L | p-value* chi-square test | ||||
| n (%) | n (%) | |||||
| Gender | NS | |||||
| Female | 10 (30) | 26 (33) | ||||
| Male | 23 (70) | 53 (67) | ||||
| Age | NS | |||||
| ≥ 9 year old | 21 (64) | 42 (53) | ||||
| < 9 year old | 12 (36) | 37 (47) | ||||
| Diagnosis | 0.006 | |||||
| ALL | 25 (76) | 38 (48) | ||||
| AML | 8 (24) | 41 (52) | ||||
| Disease status | NS | |||||
| Early disease | 13 (40) | 28 (35) | ||||
| Advanced disease | 20 (60) | 51 (65) | ||||
| Stem cell source | NS | |||||
| Cord blood | 6 (18) | 18 (23) | ||||
| Bone marrow | 27 (82) | 61 (77) | ||||
| Donor x compatibility | NS | |||||
| Related compatible | 12 (36) | 42 (53) | ||||
| Related with incompatibilities | 2 (6) | 6 (8) | ||||
| Non-related compatible | 11 (33) | 18 (23) | ||||
| Non-related with incompatibilities | 8 (15) | 13 (16) | ||||
ALL: acute lymphocyte leukemia; AML: myeloid leukemia; NS: non-significant